Recent Project News
***
News Round-Up
(for more, please follow @pharmed_out on Twitter!)
This month, ProPublica updated their wildly useful Dollars for Docs database with new 2013 data. Find industry payments to physician and other information by state, drug, company and more: http://projects.propublica.org//docdollars/
March 3: ProPublica: "As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets" http://www.propublica.org/article/as-full-disclosure-nears-doctors-pay-for-drug-talks-plummets
March 4: TwinCities.com: "Nearly 1,000 sue Medtronic over Infuse bone growth product" http://www.twincities.com/business/ci_25275263/nearly-1-000-sue-medtronic-over-infuse-bone
March 5: ANSA: "Novartis and Roche fined over 180 mn euros by anti-trust" http://www.ansa.it/web/notizie/rubriche/english/2014/03/05/Novartis-Roche-fined-180-mn-euros-anti-trust_10182795.html
March 13: Wall Street Journal: "The Pharmaceutical Sales Rep Lives to Fight Another Day" http://blogs.wsj.com/corporate-intelligence/2014/03/13/the-pharmaceutical-sales-rep-lives-to-fight-another-day/
March 15: Long Island Newsday: "Novartis gave doctors thousands to prescribe pills, feds allege" http://www.newsday.com/news/health/novartis-gave-doctors-thousands-to-prescribe-pills-feds-allege-1.7404245
March 17: New York Times "Well": "A Surgical Procedure’s Risks, Unmentioned" http://well.blogs.nytimes.com/2014/03/17/a-surgical-procedures-risks-unmentioned/
March 17: Bloomberg: "Glaxo to Bring Doctors In-House as Educational Speakers" http://www.bloomberg.com/news/2014-03-17/glaxo-to-bring-doctors-in-house-as-speakers-in-marketing-reform.html
March 19: Pacific Business News: "Hawaii attorney general sues makers of drug Plavix alleging unfair and deceptive marketing" http://www.bizjournals.com/pacific/news/2014/03/19/hawaii-attorney-general-files-lawsuit-against.html
March 21: Kaiser Health News: "FDA Finds Medical Device Recalls Nearly Doubled In 10 Years" http://www.kaiserhealthnews.org/Daily-Reports/2014/March/21/medical-device-recalls.aspx
March 24: The Atlantic: "For Depression, Prescribing Exercise Before Medication" http://www.theatlantic.com/health/archive/2014/03/for-depression-prescribing-exercise-before-medication/284587/
March 25: The Boston Globe: "Doctors draw critics for aid from drug firms" http://www.bostonglobe.com/metro/2014/03/24/drug-companies-extra-payments-researchers-raise-conflict-interest-concerns/N2xZV00WnLGhaHGH3c07OK/story.html
March 25: Wall Street Journal: "A High Stakes Battle Over Testosterone" http://blogs.wsj.com/corporate-intelligence/2014/03/25/a-high-stakes-battle-over-testosterone/
March 26: Medscape: "Statin Expansion: Hold the Rx" http://www.medscape.com/viewarticle/822462
March 26: Bloomberg: "Obamacare Spurs Merck, Glaxo to End Co-Pay Aid; Boost to Middle Class a Kickback?" http://www.bloomberg.com/news/2014-03-26/obamacare-causes-merk-glaxo-to-end-co-pay-assistance.html
March 28: ProPublica: "Reporting Recipe: Dollars for Docs" http://www.propublica.org/article/reporting-recipe-dollars-for-docs
March 28: Reuters: "U.S. wants at least $1 billion from drugmakers who delay generics" http://in.reuters.com/article/2014/03/28/us-usa-antitrust-drugs-idINBREA2R1A820140328
March 31: FiercePharma: "Massachusetts bans Zogenix's controversial new painkiller Zohydro" http://www.fiercepharma.com/story/massachusetts-bans-zogenixs-controversial-new-painkiller-zohydro/2014-03-31
***
If you know of any events that should be featured in the
PharmedOut newsletter, please let us know!